Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20020092535 A1
Publication typeApplication
Application numberUS 10/062,409
Publication dateJul 18, 2002
Filing dateFeb 5, 2002
Priority dateJun 19, 1996
Also published asUS5662124, US5908028, US6363939
Publication number062409, 10062409, US 2002/0092535 A1, US 2002/092535 A1, US 20020092535 A1, US 20020092535A1, US 2002092535 A1, US 2002092535A1, US-A1-20020092535, US-A1-2002092535, US2002/0092535A1, US2002/092535A1, US20020092535 A1, US20020092535A1, US2002092535 A1, US2002092535A1
InventorsPeter Wilk
Original AssigneeWilk Patent Development Corp.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Coronary artery by-pass method
US 20020092535 A1
Abstract
A cardiovascular treatment method utilizes an elongate flexible surgical instrument (e.g., catheter) having a distal end. A distal end portion of the instrument is inserted into a vascular system of a patient. A surgical head at the distal end of the instrument is positioned so that the head is disposed adjacent to myocardium tissue of the patient. The head is operated to form a recess in the myocardium tissue. Prior to operating the head to form the recess, a thickness of the myocardium tissue is measured, the recess formed during the operation having a length determined in accordance with the measured thickness of the myocardium tissue. The thickness measurement partially determines the length of the recess. The angle of entry of the recess with respect to the heart wall also partially determines the length of the recess: the greater the angle, the longer the recess can be for a given myocardium thickness.
Images(3)
Previous page
Next page
Claims(17)
What is claimed is:
1. A cardiovascular treatment method comprising the steps of:
providing an elongate flexible surgical instrument having a distal end;
inserting a distal end portion of said instrument into a vascular system of a patient;
disposing a surgical head at said distal end of said instrument so that said head is disposed adjacent to myocardium tissue of the patient;
operating said head to form a recess in the myocardium tissue; and
prior to operating said head to form said recess, measuring a thickness of said myocardium tissue, said recess having a length determined in accordance with the measured thickness of said myocardium tissue.
2. The method set forth in claim 1 wherein measuring said thickness includes generating an ultrasonic pressure wave, sensing reflected pressure waves and analyzing the reflected pressure waves to determine said thickness.
3. The method set forth in claim 2 wherein the generating of said ultrasonic pressure wave includes operating a transducer disposed at said distal end of said instrument.
4. The method set forth in claim 1 wherein measuring said thickness includes operating a magnetic resonance imaging machine.
5. The method set forth in claim 1 wherein measuring said thickness includes operating a computer aided tomography scanning machine.
6. The method set forth in claim 1 wherein measuring said thickness includes taking an echocardiogram.
7. The method set forth in claim 1 wherein said recess terminates in said myocardium tissue.
8. The method set forth in claim 1 wherein distal end portion is inserted into a left ventricle of the patient, said head being disposed adjacent to an inner side of said myocardium tissue, inside said left ventricle, said recess extending from said left ventricle into said myocardium tissue.
9. The method set forth in claim 8 wherein said recess terminates in said myocardium tissue.
10. The method set forth in claim 1 wherein said surgical head is a contact laser tip, the operating of said head including transmitting monochromatic coherent electromagnetic radiation through said tip to said myocardium tissue.
11. The method set forth in claim 1 wherein said surgical head includes a drill tip, the operating of said head including pushing said drill tip into said myocardium tissue and rotating said drill tip during said step of pushing.
12. The method set forth in claim 1 wherein the operating of said surgical head is implemented during diastole.
13. The method set forth in claim 12, further comprising operating a computer to synchronize the operating of said surgical head with the rhythm of said heart.
14. The method set forth in claim 1 wherein said surgical head is operated so that said recess extends only partially through said myocardium tissue from a coronary artery of the patient.
15. The method set forth in claim 1 wherein said surgical head is operated so that said recess extends only partially through said myocardium tissue from the left ventricle of the patient.
16. A method for supplying blood to the heart, comprising the step of directing blood directly into the myocardium via at least one recess formed surgically in the myocardium and extending only partially through the myocardium and only within the myocardium.
17. The method set forth in claim 16 wherein said step of directing includes the steps of, during diastole, guiding blood into said myocardium through said recess and, during systole, closing said recess.
Description
    BACKGROUND OF THE INVENTION
  • [0001]
    This invention relates to a method for effectuating a coronary artery bypass.
  • [0002]
    Coronary arteries frequently become clogged with plaque which at the very least impairs the efficiency of the heart's pumping action and can lead to heart attack. The conventional treatment for a clogged coronary artery is a coronary by-pass operation wherein one or more venous segments are inserted between the aorta and the coronary artery. The inserted venous segments or transplants by-pass the clogged portion of the coronary artery and thus provide for a free or unobstructed flow of blood to the heart.
  • [0003]
    Such conventional coronary artery by-pass surgery is expensive, time-consuming, and traumatic to the patient. Hospital stay subsequent to surgery and convalescence are prolonged.
  • [0004]
    A new coronary artery by-pass technique is disclosed in U.S. Pat. No. 5,429,144. That technique utilizes a stent made of a biocompatible material and comprises steps of moving the stent in a collapsed configuration through a blood vessel of a patient's vascular system to the patient's heart, inserting the stent in the patient's myocardium so that the stent extends at least partially through the myocardium and only within the myocardium, and upon the disposition of the stent in the myocardium, expanding the stent from the collapsed configuration to a substantially tubular expanded configuration so that a blood flow path is formed at least partially through the myocardium.
  • [0005]
    Pursuant to U.S. Pat. No. 5,429,144, the stent may be disposed in the myocardium so that it extends only partially through the myocardium, from a coronary artery, upstream of a vascular obstruction, or from the left ventricle of the heart. Alternatively, the stent may extend completely through the myocardium to establish a blood flow path from the left ventricle to a coronary artery, downstream of a vascular obstruction. In any case, the stent is deployed so that it extends only within the myocardium and does not protrude beyond the heart tissues, either into the left ventricle or into the coronary artery.
  • [0006]
    Where the stent of U.S. Pat. No. 5,429,144 extends only partially through the myocardium and thus terminates within the cardiac tissues, the stent guides blood directly into the heart tissues and particularly into cardiac vesicles which naturally occur in the myocardium. The blood is naturally distributed from the vesicles into the cardiac tissues and is collected by the veins of the heart. Where the stent terminates within the myocardium and extends from a coronary artery, upstream of a vascular obstruction, the stent maintains its expanded form during diastole, so that blood pumped from the heart is forced into the stent and from thence into the cardiac tissues. Where the stent terminates within the myocardium and extends from the left ventricle, the stent may collapse during systole, under the compressive forces exerted by the contracting heart muscle. In that case, blood is delivered to the myocardium during diastole: blood flows into the stent from the left ventricle as the ventricle is filling with blood. Alternatively, where the stent terminates within the myocardium and extends from the left ventricle, the stent may maintain its expanded form during systole, despite the compressive forces exerted by the contracting heart muscle. In that case, blood is forced into the stent and from thence into the cardiac tissues during heart contraction.
  • [0007]
    According to U.S. Pat. No. 5,429,144, the coronary bypass method further comprises inserting a distal end portion of a catheter into the perforation or recess prior to the ejection of the stent, and sensing pressure on the catheter along the distal end portion, thereby determining a thickness of the myocardium at the perforation or recess. The stent is cut from a piece of stent material so that the stent has a length corresponding to the sensed or measured thickness of the myocardium at the perforation or recess.
  • [0008]
    U.S. Pat. No. 5,429,144 describes the use of a drill head during diastole to cut a perforation into the myocardium. The synchronization or coordination of the drilling and stent ejecting steps with heart action is implementable by computer. Where the stent is disposed in the myocardium so that the stent extends only partially through the myocardium from the patient's left ventricle, the stent is inserted into the myocardium from the left ventricle. Accordingly, a distal end of the catheter is passed into the left ventricle prior to the deployment of the stent, while the stent is moved in its collapsed configuration through the catheter and into the left ventricle of the heart.
  • OBJECTS OF THE INVENTION
  • [0009]
    An object of the present invention is to provide an improved method for forming a coronary artery by-pass to thereby enable the oxygenation of cardiac tissues.
  • [0010]
    Another object of the present invention is to provide a method for forming a coronary artery by-pass which does not require leaving a device in the patient.
  • [0011]
    A further object of the present invention is to provide such a method which is less invasive and less traumatic to the patient than conventional by-pass surgery.
  • SUMMARY
  • [0012]
    Basically, the present invention is directed to a stent-less coronary artery by-pass wherein one or more recesses are formed in the myocardium. The recesses open sufficiently during diastole to permit blood flow into the myocardium and the vesicles therein.
  • [0013]
    A cardiovascular treatment method in accordance with the present invention utilizes an elongate flexible surgical instrument (e,.g. catheter) having a distal end. A distal end portion of the instrument is inserted into a vascular system of a patient. A surgical head at the distal end of the instrument is positioned so that the head is disposed adjacent to myocardium tissue of the patient. The head is operated to form a recess in the myocardium tissue. Prior to operating the head to form the recess, a thickness of the myocardium tissue is measured, the recess formed during the operation having a length determined in accordance with the measured thickness of the myocardium tissue. The thickness measurement partially determines the length of the recess. The angle of entry of the recess with respect to the heart wall also partially determines the length of the recess: the greater the angle, the longer the recess can be for a given myocardium thickness.
  • [0014]
    The thickness of the myocardium may be measured by generating an ultrasonic pressure wave, sensing reflected pressure waves and analyzing the reflected pressure waves to determine the thickness. The ultrasonic pressure wave generator (e.g., a piezoelectric crystal) and the ultrasonic wave sensor (also a piezoelectric crystal) may be disposed in the catheter wall at the distal tip thereof, or at the distal tip of an ancillary instrument inserted through a lumen of the catheter.
  • [0015]
    Measuring the thickness of the myocardium may be implemented by operating a computer aided tomography scanning machine, a magnetic resonance imaging machine or an echocardiogram device.
  • [0016]
    Generally, it is contemplated that the recess terminates in the myocardium tissue and is formed from the left ventricle of the patient. Accordingly, the surgical head is disposed adjacent to an inner side of the myocardium tissue, inside the left ventricle, so that the recess extends from the left ventricle
  • [0017]
    According to a feature of the present invention, the surgical head is a contact laser tip. In that case, operating the surgical head includes transmitting monochromatic coherent electromagnetic radiation (laser energy) through the contact laser tip to the myocardium tissue. Alternatively, the surgical head may include a drill tip, the operating of the head including pushing the drill tip into the myocardium tissue and rotating the drill tip during the step of pushing.
  • BRIEF DESCRIPTION OF THE DRAWING
  • [0018]
    [0018]FIG. 1 is a schematic cross-sectional view of a human heart, showing a plurality of recesses formed in the myocardium for providing a plurality of pathways for guiding blood directly into the cardiac tissues from the left ventricle, in accordance with the present invention.
  • [0019]
    [0019]FIG. 2 is a partial cross-sectional view, on a larger scale, showing one of the recesses of FIG. 1.
  • [0020]
    [0020]FIG. 3 is partially a schematic longitudinal cross-sectional view and partially a block diagram of an instrument assembly for forming the recesses shown in FIG. 1.
  • [0021]
    [0021]FIG. 4 is partially a schematic longitudinal cross-sectional view and partially a block diagram of another instrument assembly for forming the recesses shown in FIG. 1.
  • DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • [0022]
    The present invention seeks to oxygenate the cardiac muscle or myocardium MYO (FIG. 1) where a coronary artery AC is blocked with vascular plaque material VP. To that end, a distal end portion of an angioplastic instrument 12 or 14 (FIGS. 3, 4) is inserted through a femoral artery (not shown) and the aorta AO into the left ventricle VL. More particularly, a distal end of a steerable catheter 16 or 18 (FIGS. 3, 4) is inserted along a predetermined path 92, 94, 96 through the vascular system of the patient and into left ventricle VL. Instrument 12 or 14 is then operated to form a plurality of recesses 86, 88 and 90 in myocardium MYO for providing a plurality of pathways for guiding blood directly into the cardiac tissues from left ventricle VL. Recesses 86, 88, and 90 extend from left ventricle VL and terminate within myocardium MYO. Each recess 86, 88, and 90 thus extends only partially into myocardium MYO.
  • [0023]
    As illustrated in FIG. 3, angioplastic surgical instrument 12 includes a piezoelectric transducer 20 disposed at a distal tip of catheter 16 and electrically connected to an ultrasonic frequency generator 22. Another piezoelectric transducer 24 disposed at the distal tip of catheter 16 is operatively coupled to a wave analyzer 26 which serves to determine the thickness of myocardium MYO upon disposition of the distal end of catheter 16 inside left ventricle VL. Wave analyzer 26 is connected to a display 28 for indicating a computed heart wall thickness to a vascular surgeon.
  • [0024]
    As further illustrated in FIG. 3, an optical fiber 30 is inserted through a lumen 32 of catheter 16. At a proximal end, fiber 30 extends to a laser source 34, while at a distal end fiber 30 is provided with a surgical head in the form of a tapered contact tip 36 of conventional crystalline material. Tip 36 delivers coherent monochromatic electromagnetic radiation from laser source 34 to target tissues of the patient's heart HP (FIG. 1). A position encoder 38 is operatively linked to fiber 30 for measuring a linear displacement of the fiber during the formation of recesses 86, 88, 90. Encoder 38 is connected to display 28 for indicating a measured fiber displacement to a vascular surgeon.
  • [0025]
    As depicted in FIG. 4, catheter 18 is provided with a pair of lumens 40 and 42 which receive an ultrasonic probe 44 and an optical fiber 46, respectively. Ultrasonic probe 44 includes an electroacoustic piezoelectric transducer 48 disposed at a distal tip of the probe and electrically connected to an ultrasonic frequency generator 50. An acoustoelectric piezoelectric transducer 52 also disposed at the distal tip of probe 44 is operatively coupled to a wave analyzer 54. Analyzer 54 processes reflected ultrasonic wave pressures, sensed by transducer 52, to determine the thickness of myocardium MYO (FIG. 1) upon disposition of the distal end of catheter 18 with probe 44 inside left ventricle VL. The results of the thickness computations of analyzer 54 are transmitted to a monitor 56 for display.
  • [0026]
    As additionally depicted in FIG. 4, optical fiber 46 extends at one end to a laser source 58 and is provided at an opposite end with a surgical head in the form of a tapered contact tip 60. Tip 60 is made of conventional crystalline material and functions to deliver coherent monochromatic electromagnetic radiation from laser source 58 to target tissues of the patient's heart HP (FIG. 1). A position encoder 62 is coupled to fiber 46 for measuring a linear displacement of the fiber during the formation of recesses 86, 88, 90. Encoder 62 is connected to monitor 56 for indicating a measured fiber displacement.
  • [0027]
    As further shown in FIG. 4, catheter 18 incorporates in its wall a plurality of strain gauges 64 distributed along the catheter. Strain gauges 64 are operatively connected to a computer or microprocessor 66 which analyzes the signals from the strain gauges to determine the configuration of catheter 18 inside the patient. The computed configuration is displayed on monitor 56, together with an image of internal organs of the patient. The image of the internal organs is produced, for example, by magnetic resonance imaging (MRI), computer aided tomography (CAT) or an echocardiograph.
  • [0028]
    Upon insertion of the distal end of catheter 16 or 18 into left ventricle VL and upon the orientation of the catheter tip at a predetermined angle a1 (FIG. 2) with respect to the perpendicular 98 to the myocardium MYO, an a-c electrical current of ultrasonic frequency is transmitted from generator 22 or 50 to transducer 20 or 48 to produce an ultrasonic pressure wave. This pressure wave is reflected from inner and outer surfaces (not designated) of myocardium MY. The reflected ultrasonic pressure waves are sensed by transducer 24 or 52 and analyzed by analyzer 26 or 54 to determine the thickness of myocardium MYO in an area located immediately in front of the distal end of catheter 16 or probe 44. Provided with cardiac wall thickness information via display 28 or monitor 56, a vascular surgeon can determine an appropriate length for a recess 86, 88, or 90 to be formed in the myocardium. Recesses 86, 88, and 90 have a length sufficiently large to effectuate artificial cardiac vascularization but small enough to not traverse the myocardium.
  • [0029]
    Upon the determination of the entry location, entry angle a1 and the depth or length of the recess 86 to be formed, laser fiber 30 or 46 (FIGS. 3,4) is ejected from catheter 16 or 18 and contact tip 36 or 60 is placed in contact with the myocardium tissues. Laser energy is transmitted from source 34 or 58 to form recess 86 at angle a1 in myocardium MYO. Fiber 30 or 46 is advanced a predetermined distance into myocardium MYO, the distance of penetration of tip 36 or 60 being ascertained by position encoder 38 or 62.
  • [0030]
    The formation of recesses 86, 88 and 90 as described hereinabove may be implemented in part via a computer programmed to enable the timing of heart perforation, catheter insertion, and other operations so that those operations are performed only during the diastolic phase of a cardiac cycle. The programming and utilization of a computer in such a procedure will be clear to one skilled in the art from the teachings of U.S. Pat. No. 4,788,975 to Shturman et al., the disclosure of which is hereby incorporated by reference.
  • [0031]
    As stated above, it is contemplated that laser energy is transmitted along fiber 30 or 46 to form recess 86, 88 or 90 only during a diastolic phase of a cardiac cycle. In some cases, tip 36 or 60 may be left in place in myocardium MYO during a limited number of systolic iterations, to enable completion of recess formation. Alternatively, the contact tip 36 or 60 may be removed during systole and reinserted during diastole until the recesses are formed.
  • [0032]
    After a cardiac vascularization operation as described above is completed, blood drains into recesses 86, 88, 90 from left ventricle LV and penetrates to vesicles VCS in the myocardium MYO during diastole. The blood is naturally distributed from vesicles VCS into cardiac tissues and is collected by the veins (not shown) of the heart. Even though some of the blood may return to ventricle VL during systole (and from thence to aorta AO), enough blood remains in the myocardium to provide adequate oxygen and nutrients thereto.
  • [0033]
    In addition to one or more recesses 86, 88, and 90 inserted from the left ventricle VL partially into myocardium MYO, one or more recesses may be formed to connect left ventricle VL with coronary artery AC, as described in U.S. Pat. No. 5,429,144, the disclosure of which is hereby incorporated by reference. As additionally described in U.S. Pat. No. 5,429,144, the formation of recesses 86, 88 and 90 may be implemented with a rotary drill rather than a contact laser. U.S. Pat. No. 5,429,144 also discloses steering componentry which enables an operator to control, from outside the patient, an orientation of the distal tip of catheter 16 or 18 upon insertion of the catheter into the patient.
  • [0034]
    Although the invention has been described in terms of particular embodiments and applications, one of ordinary skill in the art, in light of this teaching, can generate additional embodiments and modifications without departing from the spirit of or exceeding the scope of the claimed invention. It is to be noted, for example, that the measurement of cardiac wall thickness may be alternatively accomplished via an MRI machine, a CAT scanner or by an echocardiogram. For example, a “measuring rod” of a predetermined length may be inserted through the angioplastic catheter. A computer connected to a CAT-scanner, an MRI machine or other imaging device then automatically determines myocardium thickness by comparing the dimensions thereof to the known length of the “measuring rod.” The computer with scanner input may be additionally used to determine optimal locations and insertion angles of multiple stents, e.g., stents 86, 88, and 90.
  • [0035]
    Accordingly, it is to be understood that the drawings and descriptions herein are profferred by way of example to facilitate comprehension of the invention and should not be construed to limit the scope thereof.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US3971363 *May 5, 1975Jul 27, 1976NasaMyocardium wall thickness transducer and measuring method
US4249541 *Apr 26, 1979Feb 10, 1981David S. PrattBiopsy device
US4658817 *Apr 1, 1985Apr 21, 1987Children's Hospital Medical CenterMethod and apparatus for transmyocardial revascularization using a laser
US4995857 *Apr 7, 1989Feb 26, 1991Arnold John RLeft ventricular assist device and method for temporary and permanent procedures
US4997431 *Aug 30, 1989Mar 5, 1991Angeion CorporationCatheter
US5106386 *Nov 2, 1990Apr 21, 1992Angelase, Inc.Catheter
US5111832 *Dec 31, 1990May 12, 1992Sanjeev SaksenaProcesses for the control of tachyarrhythmias by in vivo laser ablation of human heart tissue
US5180366 *Oct 10, 1990Jan 19, 1993Woods W TApparatus and method for angioplasty and for preventing re-stenosis
US5193546 *May 15, 1991Mar 16, 1993Alexander ShaknovichCoronary intravascular ultrasound imaging method and apparatus
US5287861 *Oct 30, 1992Feb 22, 1994Wilk Peter JCoronary artery by-pass method and associated catheter
US5292309 *Jan 22, 1993Mar 8, 1994Schneider (Usa) Inc.Surgical depth measuring instrument and method
US5327913 *Mar 25, 1992Jul 12, 1994Taheri Syde APercutaneus cardiomyoplasty method
US5330486 *Nov 25, 1992Jul 19, 1994Wilk Peter JLaparoscopic or endoscopic anastomosis technique and associated instruments
US5380316 *Jun 16, 1993Jan 10, 1995Advanced Cardiovascular Systems, Inc.Method for intra-operative myocardial device revascularization
US5389096 *Feb 25, 1993Feb 14, 1995Advanced Cardiovascular SystemsSystem and method for percutaneous myocardial revascularization
US5409012 *Dec 30, 1993Apr 25, 1995Boston Scientific CorporationSample collection using catheter with expandable member
US5409019 *Nov 3, 1993Apr 25, 1995Wilk; Peter J.Coronary artery by-pass method
US5411552 *Jun 14, 1994May 2, 1995Andersen; Henning R.Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis
US5423744 *Oct 25, 1993Jun 13, 1995Gencheff; NelsonCatheter system for the deployment of biological material
US5429144 *Apr 5, 1994Jul 4, 1995Wilk; Peter J.Coronary artery by-pass method
US5533957 *May 18, 1995Jul 9, 1996Trustees Of Boston UniversityMethod of tissue retroperfusion
US5593434 *Jun 7, 1995Jan 14, 1997Advanced Cardiovascular Systems, Inc.Stent capable of attachment within a body lumen
US5611778 *May 12, 1993Mar 18, 1997VygonSurgical instrument for performing epidural anesthesia
US5618299 *Aug 8, 1995Apr 8, 1997Advanced Cardiovascular Systems, Inc.Ratcheting stent
US5725523 *Mar 29, 1996Mar 10, 1998Mueller; Richard L.Lateral-and posterior-aspect method and apparatus for laser-assisted transmyocardial revascularization and other surgical applications
US5728091 *Jun 7, 1995Mar 17, 1998Cardiogenesis CorporationOptical fiber for myocardial channel formation
US5733267 *May 29, 1996Mar 31, 1998Scimed Life Systems, Inc.Pull back stent delivery system
US5738096 *Feb 1, 1996Apr 14, 1998Biosense, Inc.Cardiac electromechanics
US5738680 *Apr 5, 1996Apr 14, 1998Eclipse Surgical Technologies, Inc.Laser device with piercing tip for transmyocardial revascularization procedures
US5746709 *Apr 25, 1996May 5, 1998Medtronic, Inc.Intravascular pump and bypass assembly and method for using the same
US5758663 *Apr 5, 1996Jun 2, 1998Wilk; Peter J.Coronary artery by-pass method
US5766164 *Jul 3, 1996Jun 16, 1998Eclipse Surgical Technologies, Inc.Contiguous, branched transmyocardial revascularization (TMR) channel, method and device
US5782823 *Apr 5, 1996Jul 21, 1998Eclipse Surgical Technologies, Inc.Laser device for transmyocardial revascularization procedures including means for enabling a formation of a pilot hole in the epicardium
US5860951 *Nov 22, 1996Jan 19, 1999Arthrocare CorporationSystems and methods for electrosurgical myocardial revascularization
US5873855 *Nov 22, 1996Feb 23, 1999Arthrocare CorporationSystems and methods for electrosurgical myocardial revascularization
US5885259 *Jul 17, 1997Mar 23, 1999Scimed Life Systems, Inc.Increasing radius curve catheter
US5891133 *Mar 29, 1996Apr 6, 1999Eclipse Surgical Technologies, Inc.Apparatus for laser-assisted intra-coronary transmyocardial revascularization and other applications
US5893848 *Oct 24, 1996Apr 13, 1999Plc Medical Systems, Inc.Gauging system for monitoring channel depth in percutaneous endocardial revascularization
US5908028 *Jul 11, 1997Jun 1, 1999Wilk Patent Development Corp.Coronary artery by-pass method
US5925033 *Oct 31, 1995Jul 20, 1999Cardiogenesis CorporationMethod for intra-operative myocardial revascularization
US6019756 *Jan 30, 1997Feb 1, 2000Eclipse Surgical Technologies, Inc.Laser device for transmyocardial revascularization procedures
US6027497 *Feb 3, 1997Feb 22, 2000Eclipse Surgical Technologies, Inc.TMR energy delivery system
US6032674 *Dec 31, 1997Mar 7, 2000Arthrocare CorporationSystems and methods for myocardial revascularization
US6036685 *Feb 18, 1998Mar 14, 2000Eclipse Surgical Technologies. Inc.Lateral- and posterior-aspect method for laser-assisted transmyocardial revascularization and other surgical applications
US6039727 *Jan 11, 1996Mar 21, 2000Cardiogenesis CorporationChannel forming device with penetration limiter
US6068638 *Oct 27, 1998May 30, 2000Transvascular, Inc.Device, system and method for interstitial transvascular intervention
US6080163 *Jun 15, 1998Jun 27, 2000Myocardial Stents, Inc.Device and method for trans myocardial revascularization (TMR)
US6080170 *Jan 19, 1999Jun 27, 2000Kensey Nash CorporationSystem and method of use for revascularizing stenotic bypass grafts and other occluded blood vessels
US6168614 *Feb 20, 1998Jan 2, 2001Heartport, Inc.Valve prosthesis for implantation in the body
US6168624 *May 20, 1997Jan 2, 2001Amnon SudaiApparatus and methods for revascularization and perfusion
US6171303 *Jul 2, 1998Jan 9, 2001Biosense, Inc.Methods and apparatus for myocardial revascularization
US6190353 *Oct 11, 1996Feb 20, 2001Transvascular, Inc.Methods and apparatus for bypassing arterial obstructions and/or performing other transvascular procedures
US6196230 *Sep 10, 1998Mar 6, 2001Percardia, Inc.Stent delivery system and method of use
US6231587 *Mar 11, 1999May 15, 2001Transvascular, Inc.Devices for connecting anatomical conduits such as vascular structures
US6251104 *Oct 31, 1997Jun 26, 2001Eclipse Surgical Technologies, Inc.Guiding catheter system for ablating heart tissue
US6253768 *Aug 4, 1999Jul 3, 2001Percardia, Inc.Vascular graft bypass
US6254564 *Aug 4, 1999Jul 3, 2001Percardia, Inc.Left ventricular conduit with blood vessel graft
US6261304 *Aug 4, 1999Jul 17, 2001Percardia, Inc.Delivery methods for left ventricular conduit
US6267757 *Oct 2, 1997Jul 31, 2001Eclipse Surgical Technologies, Inc.Revascularization with RF ablation
US6363939 *May 18, 1999Apr 2, 2002Wilk Patent Development Corp.Coronary artery by-pass method
US6375615 *Mar 31, 1999Apr 23, 2002Transvascular, Inc.Tissue penetrating catheters having integral imaging transducers and their methods of use
US6379319 *Oct 27, 1998Apr 30, 2002Transvascular, Inc.Systems and methods for directing and snaring guidewires
US6387119 *Mar 2, 2001May 14, 2002Percardia, Inc.Delivery methods for left ventricular conduit
US6409751 *Nov 14, 2000Jun 25, 2002Percardia, Inc.Stent delivery system and method of use
US6579311 *Jan 31, 1997Jun 17, 2003Transvascular, Inc.Method for interstitial transvascular intervention
US6582444 *Apr 10, 2001Jun 24, 2003Percardia, Inc.Blood flow conduit delivery system and method of use
US6694983 *Mar 8, 2002Feb 24, 2004Percardia, Inc.Delivery methods for left ventricular conduit
US6701932 *Jan 9, 2002Mar 9, 2004Percardia, Inc.Method and apparatus for revascularizing a coronary vessel with an implant having a tapered myocardial leg
US6709444 *May 17, 2001Mar 23, 2004Transvascular, Inc.Methods for bypassing total or near-total obstructions in arteries or other anatomical conduits
US6726677 *Mar 29, 2000Apr 27, 2004Transvascular, Inc.Stabilized tissue penetrating catheters
US6746464 *Oct 28, 1998Jun 8, 2004Transvascular, Inc.Device, system and method for interstitial transvascular intervention
US6854467 *May 1, 2001Feb 15, 2005Percardia, Inc.Methods and devices for delivering a ventricular stent
US6881199 *Apr 10, 2001Apr 19, 2005Percardia, Inc.Left ventricular conduit with blood vessel graft
US20020002349 *Apr 3, 2001Jan 3, 2002Transvascular, Inc.Systems and methods for delivering drugs to selected locations within the body
US20020004662 *Apr 10, 2001Jan 10, 2002Percardia, Inc.Blood flow conduit delivery system and method of use
US20020007138 *Apr 10, 2001Jan 17, 2002Percardia, Inc.Left ventricular conduit with blood vessel graft
US20020029079 *Jul 24, 2001Mar 7, 2002Transvascular, Inc.Devices for forming and/or maintaining connections between adjacent anatomical conduits
US20020032478 *Jul 31, 2001Mar 14, 2002Percardia, Inc.Myocardial stents and related methods of providing direct blood flow from a heart chamber to a coronary vessel
US20020045928 *May 1, 2001Apr 18, 2002Percardia, Inc.Methods and devices for delivering a ventricular stent
US20020058897 *Sep 20, 2001May 16, 2002Percardia, Inc.Designs for left ventricular conduit
US20030044315 *Sep 30, 2002Mar 6, 2003Peter BoekstegersMethod and device for the selective perfusion of fluids through blood vessels, controlled by the pressure in the blood vessels
US20030045828 *Jun 20, 2002Mar 6, 2003Wilk Peter J.Left ventricular conduits to coronary arteries and methods for coronary bypass
US20030055371 *Aug 15, 2002Mar 20, 2003Percardia, Inc.Left ventricular conduits to coronary arteries and methods for coronary bypass
US20030105514 *Jan 10, 2003Jun 5, 2003Percardia, Inc.Designs for left ventricular conduit
US20040006298 *Jun 6, 2003Jan 8, 2004Percardia, Inc.Vascular graft bypass
US20040019348 *May 21, 2003Jan 29, 2004Stevens John H.Method and apparatus for thoracoscopic intracardiac procedures
US20040037946 *Aug 22, 2003Feb 26, 2004PercardiaMethods for surface modification
US20040059280 *Apr 29, 2003Mar 25, 2004Trans Vascular, Inc.Methods and apparatus for bypassing arterial obstructions and/or performing other transvascular procedures
US20040073238 *Apr 29, 2003Apr 15, 2004Transvascular, Inc.Device, system and method for interstitial transvascular intervention
US20040106931 *Jul 11, 2003Jun 3, 2004Percardia, Inc.Left ventricular conduits and methods for delivery
US20040118415 *Dec 5, 2003Jun 24, 2004Hall Todd A.Delivery methods for left ventricular conduit
US20040122318 *Nov 14, 2003Jun 24, 2004Transvascular, Inc.Tissue penetrating catheters having integral imaging transducers and their methods of use
US20040122347 *Dec 11, 2003Jun 24, 2004Percardia, Inc.Method and apparatus for revascularizing a coronary vessel with an implant having a tapered myocardial leg
US20050004505 *Jun 23, 2004Jan 6, 2005Percardia, Inc.Designs for left ventricular conduit
US20050004648 *Jul 22, 2004Jan 6, 2005Percardia, Inc.Methods and devices for delivering a ventricular stent
US20050033220 *Aug 30, 2004Feb 10, 2005Percardia, Inc.Left ventricular conduit with blood vessel graft
US20050101903 *Nov 9, 2004May 12, 2005Percardia, Inc.Interventional diagnostic catheter and a method for using a catheter to access artificial cardiac shunts
US20050101904 *Dec 15, 2004May 12, 2005Percardia, Inc.Left ventricular conduits to coronary arteries and methods for coronary bypass
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US6582444Apr 10, 2001Jun 24, 2003Percardia, Inc.Blood flow conduit delivery system and method of use
US6605053Sep 8, 2000Aug 12, 2003Percardia, Inc.Conduit designs and related methods for optimal flow control
US6605113Apr 10, 2001Aug 12, 2003Percardia Inc.Vascular graft bypass
US6610100Apr 10, 2001Aug 26, 2003Percardia, Inc.Designs for left ventricular conduit
US6641610Aug 4, 1999Nov 4, 2003Percardia, Inc.Valve designs for left ventricular conduits
US6694983Mar 8, 2002Feb 24, 2004Percardia, Inc.Delivery methods for left ventricular conduit
US7704222Aug 30, 2004Apr 27, 2010Jenavalve Technology, Inc.Methods and conduits for flowing blood from a heart chamber to a blood vessel
US7736327May 9, 2008Jun 15, 2010Jenavalve Technology, Inc.Methods and conduits for flowing blood from a heart chamber to a blood vessel
US8216174Apr 30, 2010Jul 10, 2012Jenavalve Technology, Inc.Methods and conduits for flowing blood from a heart chamber to a blood vessel
US8597226Jun 12, 2012Dec 3, 2013Jenavalve Technology, Inc.Methods and conduits for flowing blood from a heart chamber to a blood vessel
US20020058897 *Sep 20, 2001May 16, 2002Percardia, Inc.Designs for left ventricular conduit
US20030212413 *May 1, 2003Nov 13, 2003Percardia, Inc.Blood flow conduit delivery system and method of use
US20030216801 *May 17, 2002Nov 20, 2003Heartstent CorporationTransmyocardial implant with natural vessel graft and method
US20050101903 *Nov 9, 2004May 12, 2005Percardia, Inc.Interventional diagnostic catheter and a method for using a catheter to access artificial cardiac shunts
US20050228334 *May 31, 2005Oct 13, 2005Percardia, Inc.Method to deliver blood from a heart chamber to vessel
US20060155239 *Feb 24, 2006Jul 13, 2006Percardia, Inc.Method to deliver blood from a heart chamber to vessel
Classifications
U.S. Classification128/898
International ClassificationA61B17/00, A61M25/00, A61B18/24, A61F2/02, A61B19/00
Cooperative ClassificationA61B18/24, A61B2017/22021, A61M2210/125, A61B2017/00703, A61M25/0068, A61B2017/00106, A61B2018/00392, A61B2017/00247, A61F2/2493, A61B17/2202, A61M25/0082, A61B2090/064, A61B2090/3784, A61B34/20, A61B2034/2063, A61B2034/2059, A61B2090/061
European ClassificationA61B17/22B2D, A61B18/24, A61B19/52H12, A61F2/24Y